Propafenone Hydrochloride (AvKARE, Inc.)
Welcome to the PulseAid listing for the Propafenone Hydrochloride drug offered from AvKARE, Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | propafenone hydrochloride |
SUBSTANCE NAME: | PROPAFENONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-01-21 |
END MARKETING DATE: | 0000-00-00 |
Propafenone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Propafenone Hydrochloride from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 225(mg/1) |
START MARKETING DATE: | 2016-01-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-545_83e9c43d-f94d-1618-b20e-9670391beddd |
PRODUCT NDC: | 42291-545 |
APPLICATION NUMBER: | ANDA078540 |
Other PROPAFENONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: